GATA-3 positivity is present in 100% of cases of invasive lobular carcinoma of the breast and in 96% of cases of invasive ductal carcinoma of the breast and is considered a marker for breast cancer (9). This evidence concerns the gene GATA3 and invasive lobular breast carcinoma.